VREOF (Vireo Growth) Marketable Securities: $1.0 Mil (As of Mar. 2026)


VREOF Vireo Growth Inc VREOF
46 GF Score
Price $9.98
GF Value $9.69
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Vireo Growth Marketable Securities?

Vireo Growth VREOF +2.36% 46 Marketable Securities is $1.0 Mil as of Mar. 2026. GuruFocus rates VREOF with a GF Score™ of 46/100 and a GF Value™ of $9.69 (Fairly Valued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Vireo Growth's Marketable Securities for the quarter that ended in Mar. 2026 was $1.0 Mil.

Vireo Growth's annual Marketable Securities stayed the same from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($0.0 Mil) but then increased from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($1.0 Mil).

Vireo Growth  (OTCPK:VREOF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Vireo Growth Marketable Securities Related Terms

Vireo Growth Marketable Securities Historical Data

* Premium members only.

The historical data trend for Vireo Growth's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vireo Growth Marketable Securities Chart

Vireo Growth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.02

Vireo Growth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.00 1.01 1.02 1.00
VREOF
46GF Score
Vireo Growth Inc VREOF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vireo Growth Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $1.0 Mil mean?
Vireo Growth (VREOF) has a Marketable Securities of $1.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Vireo Growth and its competitors.
Is Vireo Growth's Marketable Securities too high?
Vireo Growth's current Marketable Securities is $1.0 Mil. Overall, Vireo Growth has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Marketable Securities compare to ZTS and UTHR?
Vireo Growth's Marketable Securities of $1.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Vireo Growth and its competitors. Vireo Growth's current Marketable Securities is $1.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Based on GuruFocus' analysis, Vireo Growth (VREOF) is currently considered Fairly Valued. The stock's GF Value™ is $9.69, compared to a current price of $9.98 — trading 3% above its estimated fair value. The current Marketable Securities is $1.0 Mil. Vireo Growth's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Vireo Growth (VREOF), the current Marketable Securities is $1.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vireo Growth (VREOF) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of $9.98 is trading 3% above its estimated GF Value™ of $9.69. GuruFocus considers Vireo Growth to be Fairly Valued.

Key valuation signals for VREOF:

  • Marketable Securities: $1.0 Mil
  • GF Value™: $9.69 vs. price of $9.98 (3% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the VREOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vireo Growth Business Description

Other Exchanges K95:GermanyVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
46GF Score

Get the complete analysis for VREOF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.98
Price
$9.69
GF Value